Previous 10 | Next 10 |
Becton, Dickinson press release (NYSE:BDX): Q2 Non-GAAP EPS of $3.18 beats by $0.23. Revenue of $5.01B (+2.0% Y/Y) beats by $230M. On a pre-spin basis, which includes the results of the Diabetes Care business: The company now expects fiscal year 2022 revenues to be in the range of approx...
BD REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS PR Newswire Revenue of $5.0 billion increased 2.1% as reported and 3.9% on currency-neutral basis Revenue driven by base revenue growth of 8.2% as reported, 10.2% currency-neutral, partially offset by decl...
William von Mueffling's 13F portfolio value decreased this quarter from $15.14B to $14.01B. Cantillon increased IQVIA Holdings, BlackRock, and Armstrong World Industries during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ...
BD Announces Inaugural Members of Scientific Advisory Board PR Newswire Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J. , May 2, 2022 /...
BD to Present at the BofA Securities 2022 Healthcare Conference PR Newswire FRANKLIN LAKES, N.J. , April 29, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it wil...
Becton, Dickinson (NYSE:BDX) declares $0.87/share quarterly dividend, in line with previous. Forward yield 1.36% Payable June 30; for shareholders of record June 9; ex-div June 8. See BDX Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Becton, Dickinson ...
BD Named to Forbes' 2022 List of Best Employers for Diversity PR Newswire Demonstrates Progress in Advancing 2030+ ESG Goals FRANKLIN LAKES, N.J. , April 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading glob...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry PR Newswire Developed with novel dye technology and AI guidance, new BD Horizon RealYellow™ 586 Reagents have potential to accelerate discovery and drug development in ...
Dividend Kings have a remarkable track record of 50 or more years of increasing dividend payouts. I rank the Dividend Kings using DVK Quality Snapshots, an elegant and practical system for assessing the quality of dividend growth stocks. The article provides tables and charts pres...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-08-02 11:15:08 ET Raymond James analyst issues OUTPERFORM recommendation for BDX on August 2, 2024 09:49AM ET. The previous analyst recommendation was Outperform. BDX was trading at $239.0875 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-08-02 10:10:00 ET August 2, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Tech, Automotive, Biotech and Retail Sectors. The newest automotive stocks are involved in r...
2024-08-02 09:00:11 ET Larry Biegelsen from Wells Fargo issued a price target of $280.00 for BDX on 2024-08-02 08:16:00. The adjusted price target was set to $280.00. At the time of the announcement, BDX was trading at $236.01. The overall price target consensus is at $2...